DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Volinanserin is an investigational drug.
There have been 4 clinical trials for Volinanserin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2008.
The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Diabetes Mellitus, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Sanofi and [disabled in preview].
Recent Clinical Trials for Volinanserin
|Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties||Sanofi||Phase 3|
|Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus||Sanofi||Phase 3|
|Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus||Sanofi||Phase 3|